<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04333030</url>
  </required_header>
  <id_info>
    <org_study_id>P19/12_info_aide_tabac</org_study_id>
    <nct_id>NCT04333030</nct_id>
  </id_info>
  <brief_title>Study on the Level of Information on the Risks Related to Tobacco of Persons Consulting in Psychiatry and on Access to Aids in Case of Smoking, Comparing With Persons Consulting in Diabetology or in Addictology</brief_title>
  <official_title>INFO-AIDE-TABAC Study on the Level of Information on the Risks Related to Tobacco of Persons Consulting in Psychiatry and on Access to Aids in Case of Smoking, Comparing With Persons Consulting in Diabetology or in Addictology</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Versailles Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Versailles Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      this is an observational study that involves providing a questionnaire to patients consulting
      in psychiatry, addictology (other than tobacco) and endocrinology to assess their knowledge
      of tobacco risks and access to smoking cessation aids
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">August 12, 2019</start_date>
  <completion_date type="Anticipated">December 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>to Assess the level of information on tobacco-related risks of patients with questionnaire</measure>
    <time_frame>at the end of study, average 2 month</time_frame>
    <description>to Assess the level of information on tobacco-related risks of patients monitored for psychiatric disorders by comparing them to patients monitored for an addiction other than tobacco or to patients monitored for a chronic disease</description>
  </primary_outcome>
  <primary_outcome>
    <measure>to Assess access to smoking cessation aids for smokers and ex-smokers with questionnaire</measure>
    <time_frame>at the end of study, average 2 month</time_frame>
    <description>to Assess access to smoking cessation aids for smokers and ex-smokers among psychiatric patients compared to smokers and ex-smokers among patients who have been monitored for an addiction other than tobacco or among patients who have been monitored for a chronic disease (endocrine).</description>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">310</enrollment>
  <condition>Consumption, Tobacco</condition>
  <arm_group>
    <arm_group_label>Psychiatry</arm_group_label>
    <description>patients who come for psychiatric consultation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>addictology (other than tabacco)</arm_group_label>
    <description>patients who come for addictology consultation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>endocrinology</arm_group_label>
    <description>patients who come for endocrinology consultation</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>questionnaire</intervention_name>
    <description>Tobacco Use and Risk Questionnaire</description>
    <arm_group_label>Psychiatry</arm_group_label>
    <arm_group_label>addictology (other than tabacco)</arm_group_label>
    <arm_group_label>endocrinology</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        patients who come at :

          -  Department of Psychiatry for Adults of the Hospital of Versailles of Dr N Bazin (André
             Mignot in Chesnay): CMP (Centre Médico-psychologique), HDJ (Day Hospital).

          -  Endocrinology service of Dr JP Beressi of the Hospital of Versailles (André Mignot in
             Chesnay): consultation, HDJ

          -  Addictology service CSAPA (Espace Murger) by Dr F Vorspan of the Fernand-Widal
             Hospital in Paris
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients &gt; 18 years

          -  Men and women

          -  who comes for consultation during the study

          -  Psychiatry on CMP or HDJ, regardless of diagnosis or smoking status

          -  Endocrinology in consultation or HDJ

          -  In addictology at CSAPA

        Exclusion Criteria:

          -  Patient unable to complete questionnaire (not speaking French, confused, alcoholics,
             etc.)

          -  Refusal to complete questionnaire
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Centre Hospitalier de Versailles</name>
      <address>
        <city>Le Chesnay</city>
        <zip>78150</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Ferdinand Widal</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>February 28, 2020</study_first_submitted>
  <study_first_submitted_qc>April 2, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 3, 2020</study_first_posted>
  <last_update_submitted>April 2, 2020</last_update_submitted>
  <last_update_submitted_qc>April 2, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 3, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Versailles Hospital</investigator_affiliation>
    <investigator_full_name>Dr Nadia YOUNES</investigator_full_name>
    <investigator_title>Clinical Doctor</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

